--------------------------------------------------------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
------------------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): November 3, 2005
ORION HEALTHCORP, INC.
(Exact Name of Registrant as Specified in its Charter)
Delaware 001-16587 58-1597246
(State or Other (Commission File (I.R.S. Employer
Jurisdiction of Number) Identification
Incorporation) Number)
1805 Old Alabama Road, Suite 350
Roswell, GA 30076
(Address of Principal Executive Offices) (Zip Code)
(678) 832-1800
(Registrant's Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
|_| Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
|_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
--------------------------------------------------------------------------------
Section 5 Corporate Governance and Management
Item 5.02 Departure of Directors or Principal Officers; Election of
Directors; Appointment of Principal Officers
(b) Effective November 3, 2005, Gerald M. McIntosh resigned from
the Board of Directors of Orion HealthCorp, Inc. ("the
Company").
Effective November 8, 2005, Keith G. LeBlanc resigned as
President and Director of the Company. Mr. LeBlanc will
remain as a consultant to the Company for a period of twelve
months.
Item 8.01 Other Events
On November 9, 2005, the Company issued a press release
announcing the resignation of Gerald M. McIntosh from the Board
of Directors of the Company and the resignation of Keith G.
LeBlanc as President and Director of the Company. The press
release is attached as Exhibit 99.1 to this current report.
Item 9.01 Financial Statements and Exhibits
(c) Exhibits - The following exhibits are furnished as part of this current
report:
Exhibit Description
99.1 Copy of press release issued by the Company on November 9, 2005
SIGNATURES
----------
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Company has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ORION HEALTHCORP, INC.
By: /s/ Stephen H. Murdock
----------------------
Stephen H. Murdock
Chief Financial Officer
Date: November 9, 2005
EXHIBIT INDEX
Exhibit
Number Description of Exhibits
------- -----------------------
99.1 Copy of press release issued by the Company on November 9, 2005.